Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuele Crespan

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 15, 2007
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agentsMarco Radi, Emmanuele Crespan, Giorgia Botta, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Nucleic Acids Research|July 27, 2005
Incorporation of non-nucleoside triphosphate analogues opposite to an abasic site by human DNA polymerases beta and lambdaEmmanuele Crespan, Samantha Zanoli, Anastasiya Khandazhinskaya, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzymeReynel Cancio, Romano Silvestri, Rino Ragno, et al.
Molecular Pharmacology|May 20, 2005
Diketo hexenoic acid derivatives are novel selective non-nucleoside inhibitors of mammalian terminal deoxynucleotidyl transferases, with potent cytotoxic effect against leukemic cellsGiada A Locatelli, Roberto Di Santo, Emmanuele Crespan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl InhibitorsGiulia Vignaroli, Claudio Zamperini, Elena Dreassi, et al.
Antiviral Chemistry & Chemotherapy|October 18, 2006
Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamideGabriella De Martino, Giuseppe La Regina, Rino Ragno, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigationGabriella De Martino, Giuseppe La Regina, Alessandra Di Pasquali, et al.
Nucleic Acids Research|December 21, 2016
Ribonucleotide incorporation by human DNA polymerase η impacts translesion synthesis and RNase H2 activityElisa Mentegari, Emmanuele Crespan, Laura Bavagnoli, et al.
RSC Medicinal Chemistry|May 24, 2024
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infectionsFrancesca Barbieri, Vincent Carlen, Maria Grazia Martina, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|December 15, 2007
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agentsMarco Radi, Emmanuele Crespan, Giorgia Botta, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Nucleic Acids Research|July 27, 2005
Incorporation of non-nucleoside triphosphate analogues opposite to an abasic site by human DNA polymerases beta and lambdaEmmanuele Crespan, Samantha Zanoli, Anastasiya Khandazhinskaya, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzymeReynel Cancio, Romano Silvestri, Rino Ragno, et al.
Molecular Pharmacology|May 20, 2005
Diketo hexenoic acid derivatives are novel selective non-nucleoside inhibitors of mammalian terminal deoxynucleotidyl transferases, with potent cytotoxic effect against leukemic cellsGiada A Locatelli, Roberto Di Santo, Emmanuele Crespan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl InhibitorsGiulia Vignaroli, Claudio Zamperini, Elena Dreassi, et al.
Antiviral Chemistry & Chemotherapy|October 18, 2006
Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamideGabriella De Martino, Giuseppe La Regina, Rino Ragno, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigationGabriella De Martino, Giuseppe La Regina, Alessandra Di Pasquali, et al.
Nucleic Acids Research|December 21, 2016
Ribonucleotide incorporation by human DNA polymerase η impacts translesion synthesis and RNase H2 activityElisa Mentegari, Emmanuele Crespan, Laura Bavagnoli, et al.
RSC Medicinal Chemistry|May 24, 2024
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infectionsFrancesca Barbieri, Vincent Carlen, Maria Grazia Martina, et al.
Pageof 10